208 related articles for article (PubMed ID: 2113144)
1. Prevalence of anti-HCV in patients on long-term hemodialysis.
Oguchi H; Terashima M; Tokunaga S; Kiyosawa K; Tanaka E; Furuta S; Kanno Y; Aizawa T; Nishioka K
Nihon Jinzo Gakkai Shi; 1990 Mar; 32(3):313-7. PubMed ID: 2113144
[TBL] [Abstract][Full Text] [Related]
2. [Infection of hepatitis C virus in patients with chronic renal failure undergoing hemodialysis therapy and staff members].
Miyasaka M
Nihon Jinzo Gakkai Shi; 1991 Oct; 33(10):989-99. PubMed ID: 1722830
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis virus infection (HBV and HCV) in eleven Japanese hemodialysis units.
Oguchi H; Miyasaka M; Tokunaga S; Hora K; Ichikawa S; Ochi T; Yamada K; Nagasawa M; Kanno Y; Aizawa T
Clin Nephrol; 1992 Jul; 38(1):36-43. PubMed ID: 1499167
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients.
Yakaryilmaz F; Gurbuz OA; Guliter S; Mert A; Songur Y; Karakan T; Keles H
Ren Fail; 2006; 28(8):729-35. PubMed ID: 17162434
[TBL] [Abstract][Full Text] [Related]
5. Low prevalence of anti-hepatitis C virus antibodies in female hemodialysis patients without blood transfusion: a multicenter analysis.
Nakayama E; Liu JH; Akiba T; Marumo F; Sato C
J Med Virol; 1996 Mar; 48(3):284-8. PubMed ID: 8801291
[TBL] [Abstract][Full Text] [Related]
6. HBV-DNA in hemodialysis patients infected by HCV.
Arababadi MK; Hassanshahi G; Yousefi H
Saudi J Kidney Dis Transpl; 2009 May; 20(3):398-401. PubMed ID: 19414941
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of hepatitis C virus antibody in patients on chronic hemodialysis.
Nomiyama K; Tsuji H; Ikeda K; Kawatoko T; Kashiwagi S; Nakamura S; Fujishima M
Fukuoka Igaku Zasshi; 1998 Aug; 89(8):232-7. PubMed ID: 9778915
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of hepatitis C virus infection among hemodialysis patients in a single center in Yemen.
Selm SB
Saudi J Kidney Dis Transpl; 2010 Nov; 21(6):1165-8. PubMed ID: 21060200
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of antibodies to hepatitis C virus in patients on peritoneal dialysis--a multicenter study.
Gladziwa U; Schlipköter U; Lorbeer B; Cholmakow K; Roggendorf M; Sieberth HG
Clin Nephrol; 1993 Jul; 40(1):46-52. PubMed ID: 7689431
[TBL] [Abstract][Full Text] [Related]
10. [Hepatitis B virus markers and anti-HCV antibodies in hemodialyzed patients].
Illés M; Szontágh L; Gál G
Orv Hetil; 1992 Jul; 133 Suppl 1():27-30. PubMed ID: 1630802
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of hepatitis C and B infection and HC V genotypes among hemodialysis patients in Khuzestan province, southwest Iran.
Assarehzadegan MA; Shakerinejad G; Noroozkohnejad R; Amini A; Rahim Rezaee SA
Saudi J Kidney Dis Transpl; 2009 Jul; 20(4):681-4. PubMed ID: 19587521
[TBL] [Abstract][Full Text] [Related]
12. Anti-ENA antibody profile in hepatitis C patients undergoing hemodialysis.
Batchoun RG; Al-Najdawi MA; Al-Taamary S
Saudi J Kidney Dis Transpl; 2011 Jul; 22(4):682-8. PubMed ID: 21743211
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to hepatitis C virus (HCV) in chronic renal failure (CRF) patients on conservative therapy: prevalence, risk factors and relationship to liver disease.
Fabrizi F; Marcelli D; Bacchini G; Guarnori I; Erba G; Locatelli F
Nephrol Dial Transplant; 1994; 9(7):780-4. PubMed ID: 7526275
[TBL] [Abstract][Full Text] [Related]
14. Anti-hepatitis G E2 antibody detection and its relation to serum HGV-RNA in patients with clotting disorders: high prevalence of HGV infection and spontaneous remission.
Sheng L; Soumillion A; Peerlinck K; Verslype C; Schelstraete R; Gyselinck F; Emonds MP; Hess G; Vermylen J; Desmyter J; Yap SH
Thromb Haemost; 1998 Apr; 79(4):752-5. PubMed ID: 9569187
[TBL] [Abstract][Full Text] [Related]
15. [Hepatitis B (HBV) and C (HCV) virus infections as an eventual cause of chronic hepatic damage in patients undergoing maintenance hemodialysis ].
Slizien W; Michalik D; Własiuk M; Rutkowski B; Brylowska A
Przegl Lek; 1995; 52(2):47-50. PubMed ID: 7784615
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and incidence of hepatitis C virus (HCV) in hemodialysis patients: study of risk factors.
Dentico P; Buongiorno R; Volpe A; Carlone A; Carbone M; Manno C; Proscia F; Pastore G; Schiraldi O
Clin Nephrol; 1992 Jul; 38(1):49-52. PubMed ID: 1499169
[TBL] [Abstract][Full Text] [Related]
17. [Does long-term erythropoietin therapy influence the prevalence of serum markers of hepatitis B and C in haemodialysed uraemic patients?].
Mesjasz J; Wiecek A; Gonciarz Z; Mazur W; Kokot F
Pol Merkur Lekarski; 2004 Apr; 16(94):362-7. PubMed ID: 15517934
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C infection in a pediatric dialysis population.
Jonas MM; Zilleruelo GE; LaRue SI; Abitbol C; Strauss J; Lu Y
Pediatrics; 1992 Apr; 89(4 Pt 2):707-9. PubMed ID: 1313556
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of hepatitis C virus antibodies in hemodialysis patients and dialysis staff.
Fujiyama S; Kawano S; Sato S; Tanaka M; Goto M; Taura Y; Sato T; Kawahara T; Mizuno K
Hepatogastroenterology; 1992 Apr; 39(2):161-5. PubMed ID: 1378811
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis G virus infection in hemodialysis patients from urban Delhi.
Kumar D; Arora A; Singh NP; Kohli R; Kar P; Das BC
Ren Fail; 2005; 27(1):87-93. PubMed ID: 15717640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]